NASDAQ:SRGA Surgalign (SRGA) Stock Price, News & Analysis → The CHIPS Act Motherlode (From True Market Insiders) (Ad) Free SRGA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$0.18▼$1.2252-Week Range N/AVolume8.72 million shsAverage Volume1.44 million shsMarket Capitalization$1.69 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Surgalign alerts: Email Address Ad Weiss RatingsThe ONE AI Stock to own now. (It’s not Nvidia.)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made …Click here to see the presentation now. About Surgalign Stock (NASDAQ:SRGA)Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spinal hardware implants and biomaterial products worldwide. It offers products for thoracolumbar procedures, including Streamline TL spinal fixation system, a system for degenerative and complex spine procedures; and Streamline MIS spinal fixation system, a range of implants and instruments used via a percutaneous or mini-open approach; and interbody fusion devices, as well as products for cervical procedures, such as CervAlign ACP system, a comprehensive anterior cervical plate system; Fortilink-C IBF system, a cervical interbody fusion device that utilizes TETRAfuse 3D technology; and Streamline OCT system, a range of implants used in the occipito-cervico-thoracic posterior spine. The company also provides motion preservation systems comprising Coflex Interlaminar Stabilization device for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; HPS 2.0 Universal Fixation system, a pedicle screw system used for posterior stabilization of the thoracolumbar spine; and SImmetry SI Joint Fusion system, a minimally invasive surgical implant system to decrease opioid use, pain, and disability. In addition, it develops augmented reality and artificial intelligence digital surgery platform to enable digital spine surgery. The company markets its products through independent spine and biomaterial distributors to hospitals, ambulatory surgery centers, and healthcare providers, as well as through direct sales force. The company was incorporated in 1997 and is headquartered in Deerfield, Illinois. On June 19, 2023, Surgalign Holdings, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of Texas.Read More Ad Weiss RatingsThe ONE AI Stock to own now. (It’s not Nvidia.)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made …Click here to see the presentation now. SRGA Stock News HeadlinesNovember 4, 2023 | thestreet.comSurgalign Holdings Inc.August 15, 2023 | investing.comSurgalign Holdings Inc (SRGAQ)July 10, 2023 | finance.yahoo.comRT20.BE - SURGALIGN HLDGS NEW -,001June 27, 2023 | investorplace.comWhy Is Surgalign Holdings (SRGA) Stock Up 10% Today?June 26, 2023 | benzinga.comShort Volatility Alert: Surgalign HoldingsJune 26, 2023 | investorplace.comWhy Is Surgalign Holdings (SRGA) Stock Down 23% Today?June 23, 2023 | finanznachrichten.deSurgalign Holdings, Inc.: Surgalign Receives NASDAQ Delisting Notice Following its Chapter 11 FilingJune 23, 2023 | finance.yahoo.comSurgalign Receives NASDAQ Delisting Notice Following its Chapter 11 FilingJune 20, 2023 | benzinga.comSurgalign Files For Bankruptcy, Agrees To Sell Global Hardware & Biologics BusinessJune 20, 2023 | finance.yahoo.comSurgalign Enters Into Definitive Agreement to Sell Global Hardware and Biologics Business Through a Structured Sale Process Under Chapter 11 of the U.S. Bankruptcy CodeJune 20, 2023 | investorplace.comWhy Is Surgalign (SRGA) Stock Down 55% Today?June 20, 2023 | msn.comSurgalign plummets 42% on bankruptcy filingJune 20, 2023 | msn.comSurgalign Plummets on Chapter 11 FilingJune 5, 2023 | finance.yahoo.comSurgalign (SRGA) Upgraded to Buy: What Does It Mean for the Stock?May 23, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: MoonLake Immunotherapeutics (MLTX), Athira Pharma (ATHA) and Surgalign Holdings (SRGA)May 23, 2023 | finance.yahoo.comSurgalign to Participate at ISASS 2023 – 23rd Annual Conference Sponsored by the International Society for the Advancement of Spine Surgery and Medical Education ResourcesMay 12, 2023 | finanznachrichten.deSurgalign Holdings, Inc.: Surgalign Announces First Quarter 2023 Results and Provides Update on its Business OperationsMay 11, 2023 | msn.comRecap: Surgalign Holdings Q1 EarningsMay 11, 2023 | msn.comSurgalign Holdings (SRGA) Reports Q1 Loss, Tops Revenue EstimatesMay 11, 2023 | finance.yahoo.comSurgalign Announces First Quarter 2023 Results and Provides Update on its Business OperationsMay 10, 2023 | marketwatch.comSurgalign Announces Release of HOLO(TM) AI Insights for Neurovascular ResearchMay 10, 2023 | finance.yahoo.comSurgalign Announces Release of HOLO™ AI Insights for Neurovascular ResearchMay 8, 2023 | finance.yahoo.comSurgalign Announces Release of HOLO™ AI Insights for Neurovascular ResearchMay 4, 2023 | finance.yahoo.comSurgalign Schedules First Quarter 2023 Earnings Release for May 11, 2023May 3, 2023 | finance.yahoo.comSurgalign To Collaborate with Dr. Alexander Vaccaro and Dr. Pierce Nunley to Advance HOLO™ AI Insights and its Artificial Intelligence TechnologiesSee More Headlines Receive SRGA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Surgalign and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/09/2021Today5/18/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical appliances & supplies Sub-IndustryN/A Current SymbolNASDAQ:SRGA CUSIPN/A CIK1760173 Webwww.surgalign.com Phone(224) 303-4651Fax386-418-0342Employees217Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($8.12) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-54,600,000.00 Net Margins-64.63% Pretax Margin-66.00% Return on Equity-983.11% Return on Assets-74.49% Debt Debt-to-Equity RatioN/A Current Ratio2.67 Quick Ratio2.00 Sales & Book Value Annual Sales$81.98 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value($3.81) per share Price / BookN/AMiscellaneous Outstanding Shares9,240,000Free Float8,964,000Market Cap$1.69 million OptionableOptionable Beta1.55 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Terry M. Rich (Age 55)Pres, CEO & Director Comp: $952.42kMr. David B. Lyle (Age 59)Chief Financial Officer Comp: $447.32kMr. William Scott Durall (Age 59)Chief Commercial Officer Comp: $595.66kMr. Christopher Thunander (Age 38)VP & Chief Accounting Officer Mr. Paolo G. Amoruso (Age 52)Chief Legal Officer, Gen. Counsel & Corp. Sec. Ms. Suzanne C. Zoumaras (Age 59)Chief People Officer Mr. Enrico Sangiorgio (Age 47)Exec. VP of International Mr. Olivier M. Visa (Age 54)Pres of Global OEM Mr. Marc MacKey (Age 54)Exec. VP of Digital Surgery Dr. G. Bryan Cornwall P.Eng. (Age 58)Ph.D., Exec. VP of Research and Clinical Affairs More ExecutivesKey CompetitorsNanoVibronixNASDAQ:NAOVSientraNASDAQ:SIENBone BiologicsNASDAQ:BBLGHeart Test LaboratoriesNASDAQ:HSCS180 Life SciencesNASDAQ:ATNFView All Competitors SRGA Stock Analysis - Frequently Asked Questions How were Surgalign's earnings last quarter? Surgalign Holdings, Inc. (NASDAQ:SRGA) posted its earnings results on Tuesday, November, 9th. The company reported ($3.60) earnings per share (EPS) for the quarter, missing the consensus estimate of ($2.70) by $0.90. The firm had revenue of $20.55 million for the quarter, compared to analyst estimates of $22.55 million. Surgalign had a negative trailing twelve-month return on equity of 983.11% and a negative net margin of 64.63%. During the same period in the previous year, the company posted ($3.30) EPS. When did Surgalign's stock split? Shares of Surgalign reverse split on the morning of Tuesday, May 17th 2022. The 1-30 reverse split was announced on Tuesday, May 17th 2022. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, May 17th 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. This page (NASDAQ:SRGA) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsDems have chosen Biden replacement?Paradigm PressHow Biden has already won 2024Porter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersA letter is coming from the "Bureau of the Fiscal Service".Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surgalign Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.